<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21089" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fungal Endocarditis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ojha</surname>
            <given-names>Niranjan</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dhamoon</surname>
            <given-names>Amit S.</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Niranjan Ojha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amit Dhamoon declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21089.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Endocarditis is the inflammation of the endocardium, the innermost lining of the heart. Endocarditis may be due to infective or non-infective etiologies. Fungal endocarditis is an infrequent but debilitating condition with a poor prognosis. The disease can present as native valve endocarditis, prosthetic valve endocarditis, inflammation of the endocardial surface, or cardiac device-related infective endocarditis. Diagnosing fungal endocarditis is challenging; therefore, a high index of suspicion is required for the diagnosis to be made. This activity illustrates when this condition should be considered on differential diagnosis, how to evaluate for this condition properly, and highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the typical exam findings in a patient with endocarditis.</p></list-item><list-item><p>Explain how fungal endocarditis is diagnosed.</p></list-item><list-item><p>Review the management strategies for fungal endocarditis.</p></list-item><list-item><p>Examine the role of interprofessional team members in optimizing collaboration and communication to ensure patients with fungal endocarditis receive high-quality care, which will lead to enhanced outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21089&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21089">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21089.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Endocarditis is the inflammation of the endocardium, the innermost lining of the heart. Endocarditis may be due to infective or non-infective etiologies. Fungal endocarditis is an infrequent but debilitating condition with a poor prognosis.<xref ref-type="bibr" rid="article-21089.r1">[1]</xref>&#x000a0;The disease can present as native valve endocarditis, prosthetic valve endocarditis, inflammation of the endocardial surface, and cardiac device-related infective endocarditis.<xref ref-type="bibr" rid="article-21089.r2">[2]</xref>&#x000a0;Diagnosing fungal endocarditis is challenging; therefore, a high index of suspicion is required to arrive at a diagnosis.<xref ref-type="bibr" rid="article-21089.r1">[1]</xref></p>
      </sec>
      <sec id="article-21089.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Candida spp., in particular, <italic toggle="yes">C. albicans,</italic> are the most common causative organisms of fungal endocarditis. Non-albicans species associated with fungal endocarditis include <italic toggle="yes">C. parapsilosis</italic>, <italic toggle="yes">C. tropicalis</italic>, and <italic toggle="yes">C. glabrata</italic>. <italic toggle="yes">Aspergillus sp</italic>. including&#x000a0;<italic toggle="yes">A. flavus</italic>, <italic toggle="yes">A. fumigatus</italic>, and <italic toggle="yes">A. niger</italic> are also common organisms causing fungal endocarditis.<xref ref-type="bibr" rid="article-21089.r3">[3]</xref>&#x000a0;Aspergillus species are found to be more prevalent in prosthetic valves endocarditis.<xref ref-type="bibr" rid="article-21089.r4">[4]</xref>&#x000a0;Other organisms associated with fungal endocarditis are <italic toggle="yes">Histoplasma species</italic>, <italic toggle="yes">Cryptococcus neoformans</italic>, <italic toggle="yes">Trichophyton species</italic>, <italic toggle="yes">Microsporum species</italic>, <italic toggle="yes">Fusarium species</italic>, <italic toggle="yes">Paecilomyces species,</italic> and <italic toggle="yes">Pseudallescheria boydii.</italic><xref ref-type="bibr" rid="article-21089.r5">[5]</xref>&#x000a0;Similar organisms are associated with fungal endocarditis in children. Candida infection rates decrease, and Aspergillus infection rates increase with older age in children through the age of 19.<xref ref-type="bibr" rid="article-21089.r3">[3]</xref></p>
        <p>Risk factors for fungal endocarditis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>History of open-heart surgery, prosthetic grafts</p>
          </list-item>
          <list-item>
            <p>Presence of central line</p>
          </list-item>
          <list-item>
            <p>Long term antibiotic therapy</p>
          </list-item>
          <list-item>
            <p>IN drug use</p>
          </list-item>
          <list-item>
            <p>Preexisting congenital heart disorder</p>
          </list-item>
          <list-item>
            <p>Immunosuppressed state, prolonged use of corticosteroids</p>
          </list-item>
        </list>
        <p>In most cases, fungal endocarditis affects prosthetic valves.</p>
      </sec>
      <sec id="article-21089.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Fungal endocarditis rarely occurs in healthy individuals and is associated with immunocompromised states, intravenous drug use, prolonged antibiotic use, and long-term parenteral nutrition. Individuals with prosthetic heart valves or a history of reconstructive cardiac surgery also have a higher risk of fungal endocarditis. Native valve fungal endocarditis can occur in organ transplants recipients on immunosuppressive agents, patients with myelodysplastic syndrome, and patients on long-term glucocorticoids and cytotoxic drugs.<xref ref-type="bibr" rid="article-21089.r6">[6]</xref></p>
        <p>Candida species are commensal organisms in the gastrointestinal tract, lower genital tract, and oral cavity. They are of less medical importance in an immunocompetent individual due to their inherent low virulence. The risk of candidiasis increases dramatically if the host of immunocompromised due to various reasons.<xref ref-type="bibr" rid="article-21089.r7">[7]</xref></p>
        <p>Aspergillus spp. are ubiquitous organisms in the environment. Renovation of old buildings, including hospitals and contaminated air conditioning systems, may be the source of infection as airborne transmission is common for Aspergillus spp. Extension from pre-existing intra-thoracic foci, venous access devices, or contamination of prosthetic valves is less common.<xref ref-type="bibr" rid="article-21089.r1">[1]</xref></p>
      </sec>
      <sec id="article-21089.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Source of fibrin/platelet bed, infection risk, impaired host defense mechanisms, and fungal adherence/virulence factors are necessary elements leading to fungal endocarditis.<xref ref-type="bibr" rid="article-21089.r8">[8]</xref>. The first step in the pathophysiology of fungal endocarditis is the inoculation and colonization of the bloodstream by the yeast or molds. The next step&#x000a0;is associated with the conversion of blastospores into a filamentous form, also known as phenotypic switching, which allows for the adherence to the endocardium and invasion. Different factors such as cell surface proteins in the fungal wall, the int1p protein in Candida species, and leucocyte-induced adhesion molecule allow for adherence to the heart valves. Fungal adhesion is followed by proliferation and tissue destruction.<xref ref-type="bibr" rid="article-21089.r9">[9]</xref><xref ref-type="bibr" rid="article-21089.r10">[10]</xref></p>
      </sec>
      <sec id="article-21089.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>At the initial presentation, it is very difficult to differentiate fungal endocarditis from bacterial endocarditis. Fungal endocarditis usually presents as subacute endocarditis. The most common presentation in all patients with fungal endocarditis is fever, which is usually prolonged (more than 2 weeks) and is often associated with chills, sweating, and fatigue. A new murmur, previously unrecognized murmur, or change in the quality of previously recognized murmur is another common finding in patients with suspected fungal endocarditis. Other clinical signs of fungal endocarditis include peripheral embolization in the extremities, brain, lung, kidneys, and gastrointestinal tract. Septic pulmonary embolism usually presents with fever, dyspnea, pleuritic chest pain, cough, and hemoptysis. Embolism to the gastrointestinal tract may present as an acute abdomen secondary to acute mesenteric ischemia. With valvular destruction, a patient with fungal endocarditis may present with heart failure. The patient can also present with clinical signs ranging from weight loss, clubbing, petechial rash, splenomegaly, hypotension, septic shock, and death. It is rare&#x000a0;to see peripheral findings unique to particular&#x000a0;fungal infections, such as cutaneous macro-nodules (in candidiasis).<xref ref-type="bibr" rid="article-21089.r8">[8]</xref><xref ref-type="bibr" rid="article-21089.r5">[5]</xref><xref ref-type="bibr" rid="article-21089.r11">[11]</xref><xref ref-type="bibr" rid="article-21089.r12">[12]</xref></p>
      </sec>
      <sec id="article-21089.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Since morbidity and mortality associated with fungal endocarditis is high, early diagnosis is needed for appropriate antimicrobial therapy and consideration for surgery. The diagnosis of fungal endocarditis is difficult due to the poor yield from blood cultures, which are&#x000a0;positive in less than 50% of the time.<xref ref-type="bibr" rid="article-21089.r6">[6]</xref>. Laboratory techniques such as lysis centrifugation can improve the yield from blood cultures. The blood culture yield of yeast is better than the mold.<xref ref-type="bibr" rid="article-21089.r6">[6]</xref></p>
        <p>The processing of blood cultures can be tedious and time-consuming. Quicker non-culture tests have been developed for the diagnosis of fungemia. Mannan antigen is a cell wall constituent of Candida spp. For candidemia, mannan antigen and antibody have a sensitivity and specificity of 83% and 86%, respectively.<xref ref-type="bibr" rid="article-21089.r13">[13]</xref>&#x000a0;Another cell wall polysaccharide of a fungal wall, 1,3 b-D-glucan, has a sensitivity and specificity of 69.9% and 87.1%, respectively.<xref ref-type="bibr" rid="article-21089.r11">[11]</xref>&#x000a0;Similarly, the detection of galactomannan, along with 1,3 b-D-glucan, can help to diagnose fungal endocarditis caused by Aspergillus species.<xref ref-type="bibr" rid="article-21089.r14">[14]</xref></p>
        <p>The histopathological examination is prudent in culture-negative cases and often helps to determine the diagnosis from the examination of the explanted valve, peripheral emboli, or systemic ulcers.<xref ref-type="bibr" rid="article-21089.r5">[5]</xref>. The molecular methods, such as polymerase chain reaction (PCR) to detect fungal nuclear material like DNA in blood or explanted&#x000a0;valves, can expedite the diagnosis.<xref ref-type="bibr" rid="article-21089.r15">[15]</xref></p>
        <p>Echocardiography is an important tool in diagnostic evaluation. Characteristically, the lesions are large, left-sided (bilateral lesions are common in immunocompromised patients), and occasionally non-valvular. Echocardiography can also detect abscesses of the valve ring. Trans-esophageal echocardiography is more sensitive and specific for the diagnosis of endocarditis than transthoracic echocardiography.<xref ref-type="bibr" rid="article-21089.r8">[8]</xref></p>
        <p>Blood work may reveal elevated WBC, ESR, and CRP. Thrombocytopenia is commonly seen in neonates.</p>
      </sec>
      <sec id="article-21089.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>An interprofessional approach is required for the management of fungal endocarditis. Early valve replacement surgery of the infected valve (natural or prosthetic) should be recommended (class I indication) in almost all patients with fungal endocarditis, and a long course of anti-fungal medication should be&#x000a0;initiated.<xref ref-type="bibr" rid="article-21089.r16">[16]</xref></p>
        <p>The initial antifungal treatment for <italic toggle="yes">Candida spp.</italic> endocarditis should be lipid formulation of amphotericin B with or without flucytosine or a high-dose echinocandin (caspofungin or micafungin or anidulafungin). Once the patient has stabilized, and follow-up blood cultures are negative, step-down therapy with oral fluconazole (if susceptible) is&#x000a0;recommended. If candida isolate is not susceptible to fluconazole, oral voriconazole or posaconazole can be considered.<xref ref-type="bibr" rid="article-21089.r17">[17]</xref></p>
        <p>Infected pacemakers and cardiac defibrillators should be removed, and anti-fungal therapy should be initiated. For ventricular assist devices that cannot be removed, the antifungal regimen should be started, and chronic suppressive therapy with fluconazole (if susceptible) should be continued as long as the device is in place.<xref ref-type="bibr" rid="article-21089.r17">[17]</xref>&#x000a0; &#x000a0;</p>
        <p>The endocarditis caused by <italic toggle="yes">Histoplasma capsulatum </italic>is managed with the lipid formulation of amphotericin B, followed by oral itraconazole for at least 12 months.<xref ref-type="bibr" rid="article-21089.r18">[18]</xref>&#x000a0;For <italic toggle="yes">Aspergillus</italic> endocarditis, voriconazole is used for both induction and long-term suppression.<xref ref-type="bibr" rid="article-21089.r19">[19]</xref></p>
      </sec>
      <sec id="article-21089.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Fever of unknown origin</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Bacterial endocarditis</p>
          </list-item>
          <list-item>
            <p>Myocarditis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21089.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Fungal endocarditis has a much poorer prognosis compared to bacterial causes. The key is early recognition. However, mortality rates of 10% to 75% are reported despite optimal treatment. In many cases, comorbidity is the cause of the poor prognosis.</p>
      </sec>
      <sec id="article-21089.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>CNS embolization</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Multiorgan failure</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Conduction block</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21089.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Fungal endocarditis is a serious infection with extremely high morbidity and mortality. These patients are best managed by an interprofessional team that consists of a cardiologist, infectious disease specialist, intensivist, cardiac surgeon, and internist. More importantly, the care is ideally managed and monitored in the ICU by an ICU nurse reporting to the interdisciplinary team. The key to lowering mortality is early detection and treatment. Any patient who fails to respond to antifungal agents should be referred to a cardiac surgeon. Some of these patients may require radical debridement and or valve replacement. However, even with surgical treatment, survival rates are low. Patients who are immunocompromised tend to&#x000a0;have the worst outcomes. In most case reports, recurrence is common, and the risk of embolization has been high. Most patients require long-term antifungal therapy, and hence the pharmacist should educate the patient on the need for parenteral antifungal medications. A home care nurse may be required to administer the therapy. Serial echocardiograms are often required to determine if the vegetations are resolving. For those with an embolic phenomenon, a CT of the brain may be necessary. Close communication between the team members is vital if one wants to improve outcomes.<xref ref-type="bibr" rid="article-21089.r20">[20]</xref></p>
      </sec>
      <sec id="article-21089.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21089&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21089">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/fungal-endocarditis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21089">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21089/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21089">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21089.s14">
        <title>References</title>
        <ref id="article-21089.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasha</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Al Mohajer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fungal Endocarditis: Update on Diagnosis and Management.</article-title>
            <source>Am J Med</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>129</volume>
            <issue>10</issue>
            <fpage>1037</fpage>
            <page-range>1037-43</page-range>
            <pub-id pub-id-type="pmid">27267285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>XF</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>HQ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis.</article-title>
            <source>Am J Cardiol</source>
            <year>2013</year>
            <month>Jul</month>
            <day>01</day>
            <volume>112</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-6</page-range>
            <pub-id pub-id-type="pmid">23562383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Millar</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Jugo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Fungal endocarditis in neonates and children.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2005</year>
            <season>Sep-Oct</season>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>517</fpage>
            <page-range>517-36</page-range>
            <pub-id pub-id-type="pmid">15549616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasqualotto</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Post-operative aspergillosis.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>1060</fpage>
            <page-range>1060-76</page-range>
            <pub-id pub-id-type="pmid">17002605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Al-Abdely</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sandridge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Fungal endocarditis: evidence in the world literature, 1965-1995.</article-title>
            <source>Clin Infect Dis</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-62</page-range>
            <pub-id pub-id-type="pmid">11118386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierrotti</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Baddour</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Fungal endocarditis, 1995-2000.</article-title>
            <source>Chest</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>122</volume>
            <issue>1</issue>
            <fpage>302</fpage>
            <page-range>302-10</page-range>
            <pub-id pub-id-type="pmid">12114375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mnge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Okeleye</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Vasaikar</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Apalata</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Species distribution and antifungal susceptibility patterns of Candida isolates from a public tertiary teaching hospital in the Eastern Cape Province, South Africa.</article-title>
            <source>Braz J Med Biol Res</source>
            <year>2017</year>
            <month>May</month>
            <day>15</day>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>e5797</fpage>
            <pub-id pub-id-type="pmid">28513771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fungal endocarditis.</article-title>
            <source>J Infect</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-103</page-range>
            <pub-id pub-id-type="pmid">9354341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spellberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The Pathophysiology and Treatment of Candida Sepsis.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-399</page-range>
            <pub-id pub-id-type="pmid">12228025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Raad</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Kontoyiannis</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>1153</fpage>
            <page-range>1153-5</page-range>
            <pub-id pub-id-type="pmid">11897612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varghese</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Fungal endocarditis.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-9</page-range>
            <pub-id pub-id-type="pmid">18765100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Aughenbaugh</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Septic pulmonary embolism: presenting features and clinical course of 14 patients.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>162</fpage>
            <page-range>162-6</page-range>
            <pub-id pub-id-type="pmid">16002930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mikulska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calandra</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sanguinetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poulain</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Viscoli</surname>
                <given-names>C</given-names>
              </name>
              <collab>Third European Conference on Infections in Leukemia Group</collab>
            </person-group>
            <article-title>The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.</article-title>
            <source>Crit Care</source>
            <year>2010</year>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>R222</fpage>
            <pub-id pub-id-type="pmid">21143834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maertens</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Klont</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Masson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Theunissen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meersseman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lagrou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Heinen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cr&#x000e9;pin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Eldere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tabouret</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Donnelly</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Verweij</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>May</month>
            <day>15</day>
            <volume>44</volume>
            <issue>10</issue>
            <fpage>1329</fpage>
            <page-range>1329-36</page-range>
            <pub-id pub-id-type="pmid">17443470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lefort</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chartier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sendid</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mainardi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Podglajen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Desnos-Ollivier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fontanet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bretagne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <collab>French Mycosis Study Group</collab>
            </person-group>
            <article-title>Diagnosis, management and outcome of Candida endocarditis.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>E99</fpage>
            <page-range>E99-E109</page-range>
            <pub-id pub-id-type="pmid">22329526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease.</article-title>
            <source>Heart</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>102</volume>
            <issue>13</issue>
            <fpage>992</fpage>
            <page-range>992-4</page-range>
            <pub-id pub-id-type="pmid">27288022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reboli</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>e1</fpage>
            <page-range>e1-50</page-range>
            <pub-id pub-id-type="pmid">26679628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riddell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Assi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buitrago</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Deresinski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Drevets</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Vikram</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Vergidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seidenfeld</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Wheat</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>186</fpage>
            <page-range>186-193</page-range>
            <pub-id pub-id-type="pmid">25181311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gould</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Foweraker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Sandoe</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Spry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Working Party of the British Society for Antimicrobial Chemotherapy</surname>
              </name>
            </person-group>
            <article-title>Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-89</page-range>
            <pub-id pub-id-type="pmid">22086858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21089.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siciliano</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Gualandro</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sejas</surname>
                <given-names>ONE</given-names>
              </name>
              <name>
                <surname>Ignoto</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Caramelli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mansur</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Sampaio</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Pierrotti</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Barbosa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Golebiovski</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Weksler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lamas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fortes</surname>
                <given-names>NRQ</given-names>
              </name>
              <name>
                <surname>Fortes</surname>
                <given-names>CQ</given-names>
              </name>
              <name>
                <surname>Tarasoutchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Strabelli</surname>
                <given-names>TMV</given-names>
              </name>
            </person-group>
            <article-title>Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.</article-title>
            <source>Int J Infect Dis</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>77</volume>
            <fpage>48</fpage>
            <page-range>48-52</page-range>
            <pub-id pub-id-type="pmid">30248465</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
